 | • レポートコード：QFJ1-5312 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、がん診断精密検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（画像、分子、組織/細胞、腫瘍マーカーイムノアッセイ、POC結腸がん検査）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・がん診断精密検査の市場動向 ・企業の競争状況、市場シェア ・がん診断精密検査の種類別市場規模と予測2016-2027（画像、分子、組織/細胞、腫瘍マーカーイムノアッセイ、POC結腸がん検査） ・がん診断精密検査の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・がん診断精密検査の北米市場規模2016-2027（アメリカ、カナダ） ・がん診断精密検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん診断精密検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん診断精密検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん診断精密検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Agilent Technologies、Becton Dickinson and Company、Bio-Rad Laboratories、Biocartis N.V.、Biocept、bioMerieux SA、Canon Medical Systems Corporation、Cynvenio Biosystems、Danaher Corporation、Epigenomics AG、Exosome Diagnostics、Foundation Medicine、General Electric Company、Genomic Health、Hologic、Illumina、Menarini Silicon Biosystems SpA、Myriad Genetics、NanoString Technologies、Ortho Clinical Diagnostics、QIAGEN N.V.、Randox Laboratories Ltd.、Roche Holding AG、Royal Philips N.V.、Siemens AG、Thermo Fisher Scientific、Vela Diagnostics） ・結論 |
Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves.
Market Analysis and Insights: Global Precision Cancer Diagnostic Tests Market
The global Precision Cancer Diagnostic Tests market size is projected to reach US$ 9770.4 million by 2027, from US$ 4148.6 million in 2020, at a CAGR of 12.5% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Precision Cancer Diagnostic Tests market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Precision Cancer Diagnostic Tests market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Precision Cancer Diagnostic Tests market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Precision Cancer Diagnostic Tests market.
Global Precision Cancer Diagnostic Tests Scope and Market Size
Precision Cancer Diagnostic Tests market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Precision Cancer Diagnostic Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Imaging
Molecular
Histology/Cytology
Tumor Marker Immunoassays
POC Colon Cancer Tests
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Agilent Technologies
Becton Dickinson and Company
Bio-Rad Laboratories
Biocartis N.V.
Biocept
bioMerieux SA
Canon Medical Systems Corporation
Cynvenio Biosystems
Danaher Corporation
Epigenomics AG
Exosome Diagnostics
Foundation Medicine
General Electric Company
Genomic Health
Hologic
Illumina
Menarini Silicon Biosystems SpA
Myriad Genetics
NanoString Technologies
Ortho Clinical Diagnostics
QIAGEN N.V.
Randox Laboratories Ltd.
Roche Holding AG
Royal Philips N.V.
Siemens AG
Thermo Fisher Scientific
Vela Diagnostics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Imaging
1.2.3 Molecular
1.2.4 Histology/Cytology
1.2.5 Tumor Marker Immunoassays
1.2.6 POC Colon Cancer Tests
1.3 Market by Application
1.3.1 Global Precision Cancer Diagnostic Tests Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Diagnostic Tests Market Perspective (2016-2027)
2.2 Precision Cancer Diagnostic Tests Growth Trends by Regions
2.2.1 Precision Cancer Diagnostic Tests Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Precision Cancer Diagnostic Tests Historic Market Share by Regions (2016-2021)
2.2.3 Precision Cancer Diagnostic Tests Forecasted Market Size by Regions (2022-2027)
2.3 Precision Cancer Diagnostic Tests Industry Dynamic
2.3.1 Precision Cancer Diagnostic Tests Market Trends
2.3.2 Precision Cancer Diagnostic Tests Market Drivers
2.3.3 Precision Cancer Diagnostic Tests Market Challenges
2.3.4 Precision Cancer Diagnostic Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Diagnostic Tests Players by Revenue
3.1.1 Global Top Precision Cancer Diagnostic Tests Players by Revenue (2016-2021)
3.1.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Players (2016-2021)
3.2 Global Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Precision Cancer Diagnostic Tests Revenue
3.4 Global Precision Cancer Diagnostic Tests Market Concentration Ratio
3.4.1 Global Precision Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Diagnostic Tests Revenue in 2020
3.5 Precision Cancer Diagnostic Tests Key Players Head office and Area Served
3.6 Key Players Precision Cancer Diagnostic Tests Product Solution and Service
3.7 Date of Enter into Precision Cancer Diagnostic Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Diagnostic Tests Breakdown Data by Type
4.1 Global Precision Cancer Diagnostic Tests Historic Market Size by Type (2016-2021)
4.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Type (2022-2027)
5 Precision Cancer Diagnostic Tests Breakdown Data by Application
5.1 Global Precision Cancer Diagnostic Tests Historic Market Size by Application (2016-2021)
5.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Precision Cancer Diagnostic Tests Market Size (2016-2027)
6.2 North America Precision Cancer Diagnostic Tests Market Size by Type
6.2.1 North America Precision Cancer Diagnostic Tests Market Size by Type (2016-2021)
6.2.2 North America Precision Cancer Diagnostic Tests Market Size by Type (2022-2027)
6.2.3 North America Precision Cancer Diagnostic Tests Market Size by Type (2016-2027)
6.3 North America Precision Cancer Diagnostic Tests Market Size by Application
6.3.1 North America Precision Cancer Diagnostic Tests Market Size by Application (2016-2021)
6.3.2 North America Precision Cancer Diagnostic Tests Market Size by Application (2022-2027)
6.3.3 North America Precision Cancer Diagnostic Tests Market Size by Application (2016-2027)
6.4 North America Precision Cancer Diagnostic Tests Market Size by Country
6.4.1 North America Precision Cancer Diagnostic Tests Market Size by Country (2016-2021)
6.4.2 North America Precision Cancer Diagnostic Tests Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Precision Cancer Diagnostic Tests Market Size (2016-2027)
7.2 Europe Precision Cancer Diagnostic Tests Market Size by Type
7.2.1 Europe Precision Cancer Diagnostic Tests Market Size by Type (2016-2021)
7.2.2 Europe Precision Cancer Diagnostic Tests Market Size by Type (2022-2027)
7.2.3 Europe Precision Cancer Diagnostic Tests Market Size by Type (2016-2027)
7.3 Europe Precision Cancer Diagnostic Tests Market Size by Application
7.3.1 Europe Precision Cancer Diagnostic Tests Market Size by Application (2016-2021)
7.3.2 Europe Precision Cancer Diagnostic Tests Market Size by Application (2022-2027)
7.3.3 Europe Precision Cancer Diagnostic Tests Market Size by Application (2016-2027)
7.4 Europe Precision Cancer Diagnostic Tests Market Size by Country
7.4.1 Europe Precision Cancer Diagnostic Tests Market Size by Country (2016-2021)
7.4.2 Europe Precision Cancer Diagnostic Tests Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Size (2016-2027)
8.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Type
8.2.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Type (2016-2027)
8.3 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Application
8.3.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Application (2016-2027)
8.4 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region
8.4.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Precision Cancer Diagnostic Tests Market Size (2016-2027)
9.2 Latin America Precision Cancer Diagnostic Tests Market Size by Type
9.2.1 Latin America Precision Cancer Diagnostic Tests Market Size by Type (2016-2021)
9.2.2 Latin America Precision Cancer Diagnostic Tests Market Size by Type (2022-2027)
9.2.3 Latin America Precision Cancer Diagnostic Tests Market Size by Type (2016-2027)
9.3 Latin America Precision Cancer Diagnostic Tests Market Size by Application
9.3.1 Latin America Precision Cancer Diagnostic Tests Market Size by Application (2016-2021)
9.3.2 Latin America Precision Cancer Diagnostic Tests Market Size by Application (2022-2027)
9.3.3 Latin America Precision Cancer Diagnostic Tests Market Size by Application (2016-2027)
9.4 Latin America Precision Cancer Diagnostic Tests Market Size by Country
9.4.1 Latin America Precision Cancer Diagnostic Tests Market Size by Country (2016-2021)
9.4.2 Latin America Precision Cancer Diagnostic Tests Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Diagnostic Tests Market Size (2016-2027)
10.2 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Type
10.2.1 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Type (2016-2027)
10.3 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Application
10.3.1 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Application (2016-2027)
10.4 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country
10.4.1 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Introduction
11.1.4 Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Introduction
11.2.4 Agilent Technologies Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.2.5 Agilent Technologies Recent Development
11.3 Becton Dickinson and Company
11.3.1 Becton Dickinson and Company Company Details
11.3.2 Becton Dickinson and Company Business Overview
11.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Introduction
11.3.4 Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.3.5 Becton Dickinson and Company Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Introduction
11.4.4 Bio-Rad Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Biocartis N.V.
11.5.1 Biocartis N.V. Company Details
11.5.2 Biocartis N.V. Business Overview
11.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Introduction
11.5.4 Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.5.5 Biocartis N.V. Recent Development
11.6 Biocept
11.6.1 Biocept Company Details
11.6.2 Biocept Business Overview
11.6.3 Biocept Precision Cancer Diagnostic Tests Introduction
11.6.4 Biocept Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.6.5 Biocept Recent Development
11.7 bioMerieux SA
11.7.1 bioMerieux SA Company Details
11.7.2 bioMerieux SA Business Overview
11.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Introduction
11.7.4 bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.7.5 bioMerieux SA Recent Development
11.8 Canon Medical Systems Corporation
11.8.1 Canon Medical Systems Corporation Company Details
11.8.2 Canon Medical Systems Corporation Business Overview
11.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Introduction
11.8.4 Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.8.5 Canon Medical Systems Corporation Recent Development
11.9 Cynvenio Biosystems
11.9.1 Cynvenio Biosystems Company Details
11.9.2 Cynvenio Biosystems Business Overview
11.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Introduction
11.9.4 Cynvenio Biosystems Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.9.5 Cynvenio Biosystems Recent Development
11.10 Danaher Corporation
11.10.1 Danaher Corporation Company Details
11.10.2 Danaher Corporation Business Overview
11.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Introduction
11.10.4 Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.10.5 Danaher Corporation Recent Development
11.11 Epigenomics AG
11.11.1 Epigenomics AG Company Details
11.11.2 Epigenomics AG Business Overview
11.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Introduction
11.11.4 Epigenomics AG Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.11.5 Epigenomics AG Recent Development
11.12 Exosome Diagnostics
11.12.1 Exosome Diagnostics Company Details
11.12.2 Exosome Diagnostics Business Overview
11.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Introduction
11.12.4 Exosome Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.12.5 Exosome Diagnostics Recent Development
11.13 Foundation Medicine
11.13.1 Foundation Medicine Company Details
11.13.2 Foundation Medicine Business Overview
11.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Introduction
11.13.4 Foundation Medicine Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.13.5 Foundation Medicine Recent Development
11.14 General Electric Company
11.14.1 General Electric Company Company Details
11.14.2 General Electric Company Business Overview
11.14.3 General Electric Company Precision Cancer Diagnostic Tests Introduction
11.14.4 General Electric Company Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.14.5 General Electric Company Recent Development
11.15 Genomic Health
11.15.1 Genomic Health Company Details
11.15.2 Genomic Health Business Overview
11.15.3 Genomic Health Precision Cancer Diagnostic Tests Introduction
11.15.4 Genomic Health Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.15.5 Genomic Health Recent Development
11.16 Hologic
11.16.1 Hologic Company Details
11.16.2 Hologic Business Overview
11.16.3 Hologic Precision Cancer Diagnostic Tests Introduction
11.16.4 Hologic Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.16.5 Hologic Recent Development
11.17 Illumina
11.17.1 Illumina Company Details
11.17.2 Illumina Business Overview
11.17.3 Illumina Precision Cancer Diagnostic Tests Introduction
11.17.4 Illumina Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.17.5 Illumina Recent Development
11.18 Menarini Silicon Biosystems SpA
11.18.1 Menarini Silicon Biosystems SpA Company Details
11.18.2 Menarini Silicon Biosystems SpA Business Overview
11.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Introduction
11.18.4 Menarini Silicon Biosystems SpA Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.18.5 Menarini Silicon Biosystems SpA Recent Development
11.18 Myriad Genetics
11.25.1 Myriad Genetics Company Details
11.25.2 Myriad Genetics Business Overview
11.25.3 Myriad Genetics Precision Cancer Diagnostic Tests Introduction
11.25.4 Myriad Genetics Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.25.5 Myriad Genetics Recent Development
11.20 NanoString Technologies
11.20.1 NanoString Technologies Company Details
11.20.2 NanoString Technologies Business Overview
11.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Introduction
11.20.4 NanoString Technologies Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.20.5 NanoString Technologies Recent Development
11.21 Ortho Clinical Diagnostics
11.21.1 Ortho Clinical Diagnostics Company Details
11.21.2 Ortho Clinical Diagnostics Business Overview
11.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Introduction
11.21.4 Ortho Clinical Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.21.5 Ortho Clinical Diagnostics Recent Development
11.22 QIAGEN N.V.
11.22.1 QIAGEN N.V. Company Details
11.22.2 QIAGEN N.V. Business Overview
11.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Introduction
11.22.4 QIAGEN N.V. Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.22.5 QIAGEN N.V. Recent Development
11.23 Randox Laboratories Ltd.
11.23.1 Randox Laboratories Ltd. Company Details
11.23.2 Randox Laboratories Ltd. Business Overview
11.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Introduction
11.23.4 Randox Laboratories Ltd. Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.23.5 Randox Laboratories Ltd. Recent Development
11.24 Roche Holding AG
11.24.1 Roche Holding AG Company Details
11.24.2 Roche Holding AG Business Overview
11.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Introduction
11.24.4 Roche Holding AG Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.24.5 Roche Holding AG Recent Development
11.25 Royal Philips N.V.
11.25.1 Royal Philips N.V. Company Details
11.25.2 Royal Philips N.V. Business Overview
11.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Introduction
11.25.4 Royal Philips N.V. Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.25.5 Royal Philips N.V. Recent Development
11.26 Siemens AG
11.26.1 Siemens AG Company Details
11.26.2 Siemens AG Business Overview
11.26.3 Siemens AG Precision Cancer Diagnostic Tests Introduction
11.26.4 Siemens AG Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.26.5 Siemens AG Recent Development
11.27 Thermo Fisher Scientific
11.27.1 Thermo Fisher Scientific Company Details
11.27.2 Thermo Fisher Scientific Business Overview
11.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Introduction
11.27.4 Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.27.5 Thermo Fisher Scientific Recent Development
11.28 Vela Diagnostics
11.28.1 Vela Diagnostics Company Details
11.28.2 Vela Diagnostics Business Overview
11.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Introduction
11.28.4 Vela Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2016-2021)
11.28.5 Vela Diagnostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Imaging
Table 3. Key Players of Molecular
Table 4. Key Players of Histology/Cytology
Table 5. Key Players of Tumor Marker Immunoassays
Table 6. Key Players of POC Colon Cancer Tests
Table 7. Global Precision Cancer Diagnostic Tests Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Precision Cancer Diagnostic Tests Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Precision Cancer Diagnostic Tests Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Precision Cancer Diagnostic Tests Market Share by Regions (2016-2021)
Table 11. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Precision Cancer Diagnostic Tests Market Share by Regions (2022-2027)
Table 13. Precision Cancer Diagnostic Tests Market Trends
Table 14. Precision Cancer Diagnostic Tests Market Drivers
Table 15. Precision Cancer Diagnostic Tests Market Challenges
Table 16. Precision Cancer Diagnostic Tests Market Restraints
Table 17. Global Precision Cancer Diagnostic Tests Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Precision Cancer Diagnostic Tests Market Share by Players (2016-2021)
Table 19. Global Top Precision Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Diagnostic Tests as of 2020)
Table 20. Ranking of Global Top Precision Cancer Diagnostic Tests Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Precision Cancer Diagnostic Tests Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Precision Cancer Diagnostic Tests Product Solution and Service
Table 24. Date of Enter into Precision Cancer Diagnostic Tests Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Precision Cancer Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2016-2021)
Table 28. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Precision Cancer Diagnostic Tests Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Precision Cancer Diagnostic Tests Revenue Market Share by Application (2016-2021)
Table 32. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Precision Cancer Diagnostic Tests Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Precision Cancer Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Precision Cancer Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Precision Cancer Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Precision Cancer Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Precision Cancer Diagnostic Tests Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Precision Cancer Diagnostic Tests Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Precision Cancer Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Precision Cancer Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Precision Cancer Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Precision Cancer Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Precision Cancer Diagnostic Tests Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Precision Cancer Diagnostic Tests Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Precision Cancer Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Precision Cancer Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Precision Cancer Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Precision Cancer Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Precision Cancer Diagnostic Tests Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Precision Cancer Diagnostic Tests Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Precision Cancer Diagnostic Tests Product
Table 67. Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Agilent Technologies Company Details
Table 70. Agilent Technologies Business Overview
Table 71. Agilent Technologies Precision Cancer Diagnostic Tests Product
Table 72. Agilent Technologies Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 73. Agilent Technologies Recent Development
Table 74. Becton Dickinson and Company Company Details
Table 75. Becton Dickinson and Company Business Overview
Table 76. Becton Dickinson and Company Precision Cancer Diagnostic Tests Product
Table 77. Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 78. Becton Dickinson and Company Recent Development
Table 79. Bio-Rad Laboratories Company Details
Table 80. Bio-Rad Laboratories Business Overview
Table 81. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product
Table 82. Bio-Rad Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 83. Bio-Rad Laboratories Recent Development
Table 84. Biocartis N.V. Company Details
Table 85. Biocartis N.V. Business Overview
Table 86. Biocartis N.V. Precision Cancer Diagnostic Tests Product
Table 87. Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 88. Biocartis N.V. Recent Development
Table 89. Biocept Company Details
Table 90. Biocept Business Overview
Table 91. Biocept Precision Cancer Diagnostic Tests Product
Table 92. Biocept Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 93. Biocept Recent Development
Table 94. bioMerieux SA Company Details
Table 95. bioMerieux SA Business Overview
Table 96. bioMerieux SA Precision Cancer Diagnostic Tests Product
Table 97. bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 98. bioMerieux SA Recent Development
Table 99. Canon Medical Systems Corporation Company Details
Table 100. Canon Medical Systems Corporation Business Overview
Table 101. Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 102. Canon Medical Systems Corporation Recent Development
Table 103. Cynvenio Biosystems Company Details
Table 104. Cynvenio Biosystems Business Overview
Table 105. Cynvenio Biosystems Precision Cancer Diagnostic Tests Product
Table 106. Cynvenio Biosystems Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 107. Cynvenio Biosystems Recent Development
Table 108. Danaher Corporation Company Details
Table 109. Danaher Corporation Business Overview
Table 110. Danaher Corporation Precision Cancer Diagnostic Tests Product
Table 111. Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 112. Danaher Corporation Recent Development
Table 113. Epigenomics AG Company Details
Table 114. Epigenomics AG Business Overview
Table 115. Epigenomics AG Precision Cancer Diagnostic Tests Product
Table 116. Epigenomics AG Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 117. Epigenomics AG Recent Development
Table 118. Exosome Diagnostics Company Details
Table 119. Exosome Diagnostics Business Overview
Table 120. Exosome Diagnostics Precision Cancer Diagnostic Tests Product
Table 121. Exosome Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 122. Exosome Diagnostics Recent Development
Table 123. Foundation Medicine Company Details
Table 124. Foundation Medicine Business Overview
Table 125. Foundation Medicine Precision Cancer Diagnostic Tests Product
Table 126. Foundation Medicine Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 127. Foundation Medicine Recent Development
Table 128. General Electric Company Company Details
Table 129. General Electric Company Business Overview
Table 130. General Electric Company Precision Cancer Diagnostic Tests Product
Table 131. General Electric Company Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 132. General Electric Company Recent Development
Table 133. Genomic Health Company Details
Table 134. Genomic Health Business Overview
Table 135. Genomic Health Precision Cancer Diagnostic Tests Product
Table 136. Genomic Health Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 137. Genomic Health Recent Development
Table 138. Hologic Company Details
Table 139. Hologic Business Overview
Table 140. Hologic Precision Cancer Diagnostic Tests Product
Table 141. Hologic Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 142. Hologic Recent Development
Table 143. Illumina Company Details
Table 144. Illumina Business Overview
Table 145. Illumina Precision Cancer Diagnostic Tests Product
Table 146. Illumina Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 147. Illumina Recent Development
Table 148. Menarini Silicon Biosystems SpA Company Details
Table 149. Menarini Silicon Biosystems SpA Business Overview
Table 150. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product
Table 151. Menarini Silicon Biosystems SpA Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 152. Menarini Silicon Biosystems SpA Recent Development
Table 153. Myriad Genetics Company Details
Table 154. Myriad Genetics Business Overview
Table 155. Myriad Genetics Precision Cancer Diagnostic Tests Product
Table 156. Myriad Genetics Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 157. Myriad Genetics Recent Development
Table 158. NanoString Technologies Company Details
Table 159. NanoString Technologies Business Overview
Table 160. NanoString Technologies Precision Cancer Diagnostic Tests Product
Table 161. NanoString Technologies Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 162. NanoString Technologies Recent Development
Table 163. Ortho Clinical Diagnostics Company Details
Table 164. Ortho Clinical Diagnostics Business Overview
Table 165. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product
Table 166. Ortho Clinical Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 167. Ortho Clinical Diagnostics Recent Development
Table 168. QIAGEN N.V. Company Details
Table 169. QIAGEN N.V. Business Overview
Table 170. QIAGEN N.V. Precision Cancer Diagnostic Tests Product
Table 171. QIAGEN N.V. Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 172. QIAGEN N.V. Recent Development
Table 173. Randox Laboratories Ltd. Company Details
Table 174. Randox Laboratories Ltd. Business Overview
Table 175. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product
Table 176. Randox Laboratories Ltd. Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 177. Randox Laboratories Ltd. Recent Development
Table 178. Roche Holding AG Company Details
Table 179. Roche Holding AG Business Overview
Table 180. Roche Holding AG Precision Cancer Diagnostic TestsProduct
Table 181. Roche Holding AG Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 182. Roche Holding AG Recent Development
Table 183. Royal Philips N.V. Company Details
Table 184. Royal Philips N.V. Business Overview
Table 185. Royal Philips N.V. Precision Cancer Diagnostic Tests Product
Table 186. Royal Philips N.V. Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 187. Royal Philips N.V. Recent Development
Table 188. Siemens AG Company Details
Table 189. Siemens AG Business Overview
Table 190. Siemens AG Precision Cancer Diagnostic Tests Product
Table 191. Siemens AG Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 192. Siemens AG Recent Development
Table 193. Thermo Fisher Scientific Company Details
Table 194. Thermo Fisher Scientific Business Overview
Table 195. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product
Table 196. Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 197. Thermo Fisher Scientific Recent Development
Table 198. Vela Diagnostics Company Details
Table 199. Vela Diagnostics Business Overview
Table 200. Vela Diagnostics Precision Cancer Diagnostic Tests Product
Table 201. Vela Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2016-2021) & (US$ Million)
Table 202. Vela Diagnostics Recent Development
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Precision Cancer Diagnostic Tests Market Share by Type: 2020 VS 2027
Figure 2. Imaging Features
Figure 3. Molecular Features
Figure 4. Histology/Cytology Features
Figure 5. Tumor Marker Immunoassays Features
Figure 6. POC Colon Cancer Tests Features
Figure 7. Global Precision Cancer Diagnostic Tests Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Precision Cancer Diagnostic Tests Report Years Considered
Figure 12. Global Precision Cancer Diagnostic Tests Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Precision Cancer Diagnostic Tests Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Precision Cancer Diagnostic Tests Market Share by Regions: 2020 VS 2027
Figure 15. Global Precision Cancer Diagnostic Tests Market Share by Regions (2022-2027)
Figure 16. Global Precision Cancer Diagnostic Tests Market Share by Players in 2020
Figure 17. Global Top Precision Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Diagnostic Tests as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Precision Cancer Diagnostic Tests Revenue in 2020
Figure 19. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2016-2021)
Figure 20. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2022-2027)
Figure 21. North America Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Precision Cancer Diagnostic Tests Market Share by Type (2016-2027)
Figure 23. North America Precision Cancer Diagnostic Tests Market Share by Application (2016-2027)
Figure 24. North America Precision Cancer Diagnostic Tests Market Share by Country (2016-2027)
Figure 25. United States Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Precision Cancer Diagnostic Tests Market Share by Type (2016-2027)
Figure 29. Europe Precision Cancer Diagnostic Tests Market Share by Application (2016-2027)
Figure 30. Europe Precision Cancer Diagnostic Tests Market Share by Country (2016-2027)
Figure 31. Germany Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Precision Cancer Diagnostic Tests Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Precision Cancer Diagnostic Tests Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Precision Cancer Diagnostic Tests Market Share by Region (2016-2027)
Figure 41. China Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Precision Cancer Diagnostic Tests Market Share by Type (2016-2027)
Figure 49. Latin America Precision Cancer Diagnostic Tests Market Share by Application (2016-2027)
Figure 50. Latin America Precision Cancer Diagnostic Tests Market Share by Country (2016-2027)
Figure 51. Mexico Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Precision Cancer Diagnostic Tests Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Precision Cancer Diagnostic Tests Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Precision Cancer Diagnostic Tests Market Share by Country (2016-2027)
Figure 57. Turkey Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Precision Cancer Diagnostic Tests Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 61. Agilent Technologies Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 62. Becton Dickinson and Company Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 63. Bio-Rad Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 64. Biocartis N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 65. Biocept Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 66. bioMerieux SA Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 67. Canon Medical Systems Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 68. Cynvenio Biosystems Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 69. Danaher Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 70. Epigenomics AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 71. Exosome Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 72. Foundation Medicine Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 73. General Electric Company Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 74. Genomic Health Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 75. Hologic Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 76. Illumina Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 77. Menarini Silicon Biosystems SpA Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 78. Myriad Genetics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 79. NanoString Technologies Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 80. Ortho Clinical Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 81. QIAGEN N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 82. Randox Laboratories Ltd. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 83. Roche Holding AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 84. Royal Philips N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 85. Siemens AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 86. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 87. Vela Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2016-2021)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
肝癌診断検査のグローバル市場調査 2019年 The global Liver Cancer Diagnostic Tests market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Liver Cancer Diagnostic Tests volume and value at global level, regional level and company level. From a glob…- 世界の糞便免疫化学的診断検査市場規模・現状・予測（2021年-2027年） In a fecal immunochemical diagnostic test, antibodies are used to detect blood in the stool, which bind to a blood protein called hemoglobin found in red blood cells (RBC). A positive result of a fecal immunochemical diagnostic test may be a sign of colorectal cancer, polyps, ulcers or hemorrhoids. …
- 世界のがん精密画像市場規模・現状・予測（2021年-2027年） Precision cancer imaging system performs an important role in the detection of cancer because it offers a detailed perception into the exact location and extent of the ailment. Precision Cancer imaging is a technique for diagnosing scientific disorders, which takes into account individual variabilit…
- 世界の肝炎ウイルス診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hepatitis Viruses Diagnostic Tests Market The global Hepatitis Viruses Diagnostic Tests market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
- 世界のB型肝炎診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hepatitis B Diagnostic Tests Market The global Hepatitis B Diagnostic Tests market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…